T Stamp Inc
Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.
On October 4, 2024, Alexander Valdes, the Chief Financial Officer of T Stamp Inc., a Delaware corporation (the “Company”), submitted a notice of non-renewal of his employment agreement with the Company, providing a 90-day notice in accordance with the terms of his employment agreement, which was accepted by the Company.
Mr. Valdes is currently the Board Secretary of the Company, a position from which he also intends to resign on or before January 2, 2025.
20cc63263b
Alexander Valdes resigned as Chief Financial Officer at T Stamp Inc.
On October 4, 2024, Alexander Valdes, the Chief Financial Officer of T Stamp Inc., a Delaware corporation (the “Company”), submitted a notice of non-renewal of his employment agreement with the Company, providing a 90-day notice in accordance with the terms of his employment agreement, which was accepted by the Company.
b2024ec66c
Alexander Valdes resigned as Board Secretary at T Stamp Inc.
Mr. Valdes is currently the Board Secretary of the Company, a position from which he also intends to resign on or before January 2, 2025.
Biote CEO Christensen resigns; CFO Peterson named Interim CEO; Marc Beer Executive Chairman; FY2026 guidance reaffirmed
This filing
On October 4, 2024, Alexander Valdes, the Chief Financial Officer of T Stamp Inc., a Delaware corporation (the “Company”), submitted a notice of non-renewal of his employment agreement with the Company, providing a 90-day notice in accordance with the terms of his employment agreement, which was accepted by the Company.
Comparable filing
On June 1, 2026, the Board appointed Marc Beer as Executive Chairman of the Board, effective June 8, 2026.
Nucor EVP David Sumoski to retire June 13, 2026; receives $308,851/month for 24 months
This filing
On October 4, 2024, Alexander Valdes, the Chief Financial Officer of T Stamp Inc., a Delaware corporation (the “Company”), submitted a notice of non-renewal of his employment agreement with the Company, providing a 90-day notice in accordance with the terms of his employment agreement, which was accepted by the Company.
Comparable filing
On May 28, 2026, the Company and Mr. Sumoski entered into a Retirement, Separation, Waiver and Release Agreement (the “Retirement Agreement”) in connection with Mr. Sumoski’s retirement from employment with the Company, effective June 13, 2026.
Zaneta Koplewicz resigns as Co-President and Director of Blackstone Real Estate Income Trust
This filing
On October 4, 2024, Alexander Valdes, the Chief Financial Officer of T Stamp Inc., a Delaware corporation (the “Company”), submitted a notice of non-renewal of his employment agreement with the Company, providing a 90-day notice in accordance with the terms of his employment agreement, which was accepted by the Company.
Comparable filing
On June 2, 2026, Zaneta Koplewicz resigned from Blackstone Real Estate Income Trust, Inc. (the “Company”) as Co-President, Head of Shareholder Relations and as a member of the Company’s Board of Directors (the “Board”), effective June 24, 2026.
VisionWave appoints Einav Eliraz as CFO of subsidiary VisionWave IL; grants 500K share options
This filing
On October 4, 2024, Alexander Valdes, the Chief Financial Officer of T Stamp Inc., a Delaware corporation (the “Company”), submitted a notice of non-renewal of his employment agreement with the Company, providing a 90-day notice in accordance with the terms of his employment agreement, which was accepted by the Company.
Comparable filing
On June 1, 2026, VisionWave IL Ltd. (“VisionWave IL”), a wholly-owned subsidiary of VisionWave Holdings, Inc. (the “Company”), entered into an Employment Agreement with Mr. Einav Eliraz pursuant to which Mr. Eliraz was appointed Chief Financial Officer (“CFO”) of VisionWave IL, effective June 1, 2026.
Cue Biopharma appoints new directors, chief legal officer, and accounting officer; board size reduced
This filing
On October 4, 2024, Alexander Valdes, the Chief Financial Officer of T Stamp Inc., a Delaware corporation (the “Company”), submitted a notice of non-renewal of his employment agreement with the Company, providing a 90-day notice in accordance with the terms of his employment agreement, which was accepted by the Company.
Comparable filing
On May 29, 2026, Cue Biopharma, Inc. (the “Company”) and each of Jill Broadfoot, Peter Kiener, Frank Morich and Patrick Verheyen mutually agreed that Messrs. Kiener, Morich and Verheyen and Ms. Broadfoot would resign as members of the Board of Directors of the Company (the “Board”) and as members of the committees of the Board on which they serve, effective immediately.
Cycurion appoints Ana Garcia as CFO; Alvin McCoy III transitions to strategic advisor
This filing
On October 4, 2024, Alexander Valdes, the Chief Financial Officer of T Stamp Inc., a Delaware corporation (the “Company”), submitted a notice of non-renewal of his employment agreement with the Company, providing a 90-day notice in accordance with the terms of his employment agreement, which was accepted by the Company.
Comparable filing
the Company also announced the appointment of Ana Garcia as its new Chief Financial Officer, effective June 1, 2026.
YUM! Brands COO/CPO Tracy Skeans to transition Nov 1, 2026, retire March 1, 2028
This filing
On October 4, 2024, Alexander Valdes, the Chief Financial Officer of T Stamp Inc., a Delaware corporation (the “Company”), submitted a notice of non-renewal of his employment agreement with the Company, providing a 90-day notice in accordance with the terms of his employment agreement, which was accepted by the Company.
Comparable filing
On June 2, 2026, YUM! Brands, Inc. (the “Company”) announced that Tracy Skeans will transition from her roles as Chief Operating Officer and Chief People & Culture Officer effective on November 1, 2026 (the “Transition Date”).
Ardent Health appoints Dave Caspers as CEO, reaffirms FY 2026 EBITDA guidance
This filing
On October 4, 2024, Alexander Valdes, the Chief Financial Officer of T Stamp Inc., a Delaware corporation (the “Company”), submitted a notice of non-renewal of his employment agreement with the Company, providing a 90-day notice in accordance with the terms of his employment agreement, which was accepted by the Company.
Comparable filing
Mr. Caspers succeeds Martin J. Bonick, who separated from the Company and stepped down from the Board effective as of the Effective Date.
This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.